Sequential administration of recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: A phase I/II multicenter study

Blood

Volumn 84, Issue 7, 1994, Pages 2151-2157

  Fay, J W ^a   Lazarus, H ^a   Herzig, R ^a   Saez, R ^a   Stevens, D A ^a   Collins Jr , R H ^a   Pineiro, L A ^a   Cooper, B W ^a   DiCesare, J ^a   Campion, M ^a   Felser, J M ^a   Herzig, G ^a   Bernstein, S H ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTINEOPLASTIC AGENT; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 3; THIOTEPA;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HODGKIN DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; LUNG EDEMA; MALE; MULTICENTER STUDY; NEUTROPHIL; NONHODGKIN LYMPHOMA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RASH; SUBCUTANEOUS DRUG ADMINISTRATION; TACHYCARDIA; THORAX PAIN; THROMBOCYTE COUNT;

EID: 0027981944     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v84.7.2151.bloodjournal8472151     Document Type: Article

References (0)